Literature DB >> 16257222

In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9/TIMP-1 ratio and increased collagen type IV degradation.

Johann Sellner1, Stephen L Leib.   

Abstract

Adverse outcome in bacterial meningitis is associated with the breakdown of the blood-brain barrier (BBB). Matrix-metalloproteinases (MMPs) facilitate this process by degradation of components of the BBB. This in turn results in acute complications of bacterial meningitis including edema formation, increased intracranial pressure and subsequent ischemia. We determined the parenchymal balance of MMP-9 and TIMP-1 (tissue inhibitor of MMP) and the structural integrity of the BBB in relation to cortical damage in an infant rat model of pneumococcal meningitis. The data demonstrate that the extent of cortical damage is significantly associated with parenchymal gelatinolytic activity and collagen type IV degradation. The increased gelatinolysis was found to be associated with a brain parenchymal imbalance of MMP-9/TIMP-1. These findings provide support to the concept that MMPs mediated disruption of the BBB contributes to the pathogenesis of bacterial meningitis and that protection of the vascular unit may have neuroprotective potential.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16257222     DOI: 10.1016/j.nbd.2005.09.007

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  30 in total

1.  Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier.

Authors:  Carola Förster; Malgorzata Burek; Ignacio A Romero; Babette Weksler; Pierre-Olivier Couraud; Detlev Drenckhahn
Journal:  J Physiol       Date:  2008-02-07       Impact factor: 5.182

2.  Multiple expression of matrix metalloproteinases in murine neurocysticercosis: Implications for leukocyte migration through multiple central nervous system barriers.

Authors:  Jorge I Alvarez; Judy M Teale
Journal:  Brain Res       Date:  2008-04-01       Impact factor: 3.252

Review 3.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

4.  Expression levels of matrix metalloproteinase (MMP)-9 and its specific inhibitor TIMP-1, in septic and aseptic arthritis of the knee.

Authors:  Vasileios Christos Fotopoulos; Athina Tzinia; Matthew Tzurbakis; Vasiliki Kalfakakou; Stamatina Levidiotou-Stefanou; Anastasios Georgoulis
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-09-24       Impact factor: 4.342

5.  Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis.

Authors:  Denis Grandgirard; Christian Schürch; Philippe Cottagnoud; Stephen L Leib
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

6.  Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND.

Authors:  Carola Förster; Timo Kahles; Silke Kietz; Detlev Drenckhahn
Journal:  J Physiol       Date:  2007-02-22       Impact factor: 5.182

7.  GABAA receptor agonist mitigates homocysteine-induced cerebrovascular remodeling in knockout mice.

Authors:  Munish Kumar; Neetu Tyagi; Karni S Moshal; Utpal Sen; S B Pushpakumar; Thomas Vacek; David Lominadze; Suresh C Tyagi
Journal:  Brain Res       Date:  2008-04-20       Impact factor: 3.252

8.  Matrix metalloproteinase inhibition lowers mortality and brain injury in experimental pneumococcal meningitis.

Authors:  Fabian D Liechti; Denis Grandgirard; David Leppert; Stephen L Leib
Journal:  Infect Immun       Date:  2014-02-03       Impact factor: 3.441

9.  Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1.

Authors:  Emiri Tejima; Shuzhen Guo; Yoshihiro Murata; Ken Arai; Josephine Lok; Klaus van Leyen; Anna Rosell; Xiaoying Wang; Eng H Lo
Journal:  J Neurotrauma       Date:  2009-11       Impact factor: 5.269

10.  Dexamethasone, cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous meningitis.

Authors:  Justin A Green; Chau T H Tran; Jeremy J Farrar; Mai T H Nguyen; Phu H Nguyen; Sinh X Dinh; Nghia D T Ho; Chuong V Ly; Hien T Tran; Jon S Friedland; Guy E Thwaites
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.